{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:53:38Z","timestamp":1773921218844,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.canrad.2014.06.003","type":"journal-article","created":{"date-parts":[[2014,8,20]],"date-time":"2014-08-20T23:16:32Z","timestamp":1408576592000},"page":"430-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Papillomavirus humain et cancer ORL"],"prefix":"10.1016","volume":"18","author":[{"given":"B.","family":"Barry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ortholan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2014.06.003_bib0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/CCO.0b013e32835ff48c","article-title":"Epidemiology of head and neck squamous cell carcinoma not related to tobacco or alcohol","volume":"25","author":"Curado","year":"2013","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.canrad.2014.06.003_bib0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.canrad.2011.11.001","article-title":"Carcinomes \u00e9pidermo\u00efdes oropharyng\u00e9s li\u00e9s \u00e0 l\u2019infection par les papillomavirus humains de haut risque oncog\u00e9nique\u00a0: aspects cliniques, biologiques et perspectives th\u00e9rapeutiques","volume":"16","author":"Guihard","year":"2012","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2014.06.003_bib0015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jcv.2011.03.003","article-title":"Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France \u2013 The EDiTH VI study","volume":"51","author":"St Guily","year":"2011","journal-title":"J Clin Virol"},{"key":"10.1016\/j.canrad.2014.06.003_bib0020","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1055-9965.EPI-04-0551","article-title":"Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review","volume":"14","author":"Kreimer","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.canrad.2014.06.003_bib0025","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/tx500034c","article-title":"Prevalence of human papillomavirus in oropharyngeal squamous cell carcinoma in the united states across time","volume":"27","author":"Stein","year":"2014","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.canrad.2014.06.003_bib0030","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1200\/JCO.2006.06.1291","article-title":"Clinical implications of human papillomavirus in head and neck cancers","volume":"24","author":"Fakhry","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2014.06.003_bib0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2014.06.003_bib0040","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jnci\/djn025","article-title":"Distinct risk factors for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers","volume":"100","author":"Gillison","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canrad.2014.06.003_bib0045","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00008469-200012000-00010","article-title":"Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands","volume":"9","author":"Hemminki","year":"2000","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.canrad.2014.06.003_bib0050","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1054\/bjom.2000.0162","article-title":"Incidence of human papillomavirus 16 and 18 infection and p53 mutation in patients with oral squamous cell carcinoma in Japan","volume":"38","author":"Shima","year":"2000","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.canrad.2014.06.003_bib0055","series-title":"Recommandation pour la pratique clinique. Bilan pr\u00e9th\u00e9rapeutique des carcinomes \u00e9pidermo\u00efdes des VADS","author":"de Raucourt","year":"2012"},{"key":"10.1016\/j.canrad.2014.06.003_bib0060","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/cncr.25040","article-title":"Intensity-modulated radiotherapy outcomes for oropharyngeal squamous cell carcinoma patients stratified by p16 status","volume":"116","author":"Shoushtari","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2014.06.003_bib0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canrad.2014.06.003_bib0070","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1200\/JCO.2007.12.7597","article-title":"Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number","volume":"26","author":"Worden","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2014.06.003_bib0075","article-title":"Staging and treatment of oropharyngeal cancer in the HPV era","author":"Ward","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2014.06.003_bib0080","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/modpathol.2011.105","article-title":"Extracapsular extension is a poor predictor of disease recurrence in surgically treated oropharyngeal squamous cell carcinoma","volume":"24","author":"Lewis","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.canrad.2014.06.003_bib0085","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1002\/lary.20593","article-title":"Human papillomavirus reduces the prognostic value of nodal involvement in tonsillar squamous cell carcinomas","volume":"119","author":"Straetmans","year":"2009","journal-title":"Laryngoscope"},{"key":"10.1016\/j.canrad.2014.06.003_bib0090","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1002\/lary.23493","article-title":"Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer","volume":"122","author":"Haughey","year":"2012","journal-title":"Laryngoscope"},{"key":"10.1016\/j.canrad.2014.06.003_bib0095","doi-asserted-by":"crossref","first-page":"15s","DOI":"10.1200\/jco.2009.27.15_suppl.6003","article-title":"Survival outcomes by tumor human papillomavirus (HPV) status in stage III-IV oropharyngeal cancer (OPC) in RTOG 0129","volume":"27","author":"Gillison","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2014.06.003_bib0100","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1136\/jcp.2005.034835","article-title":"Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population","volume":"60","author":"Mitra","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.canrad.2014.06.003_bib0105","first-page":"72","article-title":"Estimation des couvertures vaccinales en France \u00e0 partir de l\u2019\u00e9chantillon g\u00e9n\u00e9raliste des b\u00e9n\u00e9ficiaires (EGB)\u00a0: exemples de la rougeole, de l\u2019h\u00e9patite B et de la vaccination HPV","volume":"8\u20139","author":"Fonteneau","year":"2013","journal-title":"Bull Epidemiol Hebd"},{"key":"10.1016\/j.canrad.2014.06.003_bib0110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2407-13-10","article-title":"Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe","volume":"13","author":"Marty","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canrad.2014.06.003_bib0115","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1016\/j.vaccine.2011.07.096","article-title":"The cost-effectiveness of male HPV vaccination in the United States","volume":"29","author":"Chesson","year":"2011","journal-title":"Vaccine"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832181400105X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832181400105X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:22:35Z","timestamp":1761135755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S127832181400105X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":23,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S127832181400105X"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2014.06.003","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Papillomavirus humain et cancer ORL","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2014.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}